Advertisement

Index by author

October 01, 1988; Volume 34,Issue 4

A

  1. Afar, R

    1. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
      S Geertsen, R Afar, J M Trifaró and M Quik
      Molecular Pharmacology October 1988, 34 (4) 549-556;

B

  1. Bapat, A R

    1. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
      W B Parker, A R Bapat, J X Shen, A J Townsend and Y C Cheng
      Molecular Pharmacology October 1988, 34 (4) 485-491;

  2. Barbour, K W

    1. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
      S H Berger, K W Barbour and F G Berger
      Molecular Pharmacology October 1988, 34 (4) 480-484;

  3. Barker, J L

    1. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses.
      S V Jones, J L Barker, N J Buckley, T I Bonner, R M Collins and M R Brann
      Molecular Pharmacology October 1988, 34 (4) 421-426;

  4. Beaudet, A

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

  5. Berger, F G

    1. Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.
      S H Berger and F G Berger
      Molecular Pharmacology October 1988, 34 (4) 474-479;
    2. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
      S H Berger, K W Barbour and F G Berger
      Molecular Pharmacology October 1988, 34 (4) 480-484;

  6. Berger, S H

    1. Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.
      S H Berger and F G Berger
      Molecular Pharmacology October 1988, 34 (4) 474-479;
    2. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
      S H Berger, K W Barbour and F G Berger
      Molecular Pharmacology October 1988, 34 (4) 480-484;

  7. Bernatowicz, M

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;

  8. Bochet, P

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

  9. Bonner, T I

    1. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses.
      S V Jones, J L Barker, N J Buckley, T I Bonner, R M Collins and M R Brann
      Molecular Pharmacology October 1988, 34 (4) 421-426;

  10. Brann, M R

    1. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses.
      S V Jones, J L Barker, N J Buckley, T I Bonner, R M Collins and M R Brann
      Molecular Pharmacology October 1988, 34 (4) 421-426;

  11. Broder, S

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  12. Buckley, N J

    1. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses.
      S V Jones, J L Barker, N J Buckley, T I Bonner, R M Collins and M R Brann
      Molecular Pharmacology October 1988, 34 (4) 421-426;

  13. Buja, L M

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;

C

  1. Caffrey, J M

    1. A monoclonal antibody specifically modulates dihydropyridine-sensitive calcium current in BC3H1 myocytes.
      J M Caffrey and M C Farach
      Molecular Pharmacology October 1988, 34 (4) 518-526;

  2. Calianos, T A

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;

  3. Chapekar, M S

    1. The epidermal growth factor- and interferon-independent effects of double-stranded RNA in A431 cells.
      M S Chapekar, M C Knode and R I Glazer
      Molecular Pharmacology October 1988, 34 (4) 461-466;

  4. Chaudhry, A

    1. Relationship between delta-9-tetrahydrocannabinol-induced arachidonic acid release and secretagogue-evoked phosphoinositide breakdown and Ca2+ mobilization of exocrine pancreas.
      A Chaudhry, R H Thompson, R P Rubin and S G Laychock
      Molecular Pharmacology October 1988, 34 (4) 543-548;

  5. Cheng, Y C

    1. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
      W B Parker, A R Bapat, J X Shen, A J Townsend and Y C Cheng
      Molecular Pharmacology October 1988, 34 (4) 485-491;

  6. Chi-Rosso, G

    1. Subcellular localization of leukotriene D4 receptors in sheep tracheal smooth muscle.
      S Mong, G Chi-Rosso, D W Hay and S T Crooke
      Molecular Pharmacology October 1988, 34 (4) 590-596;

  7. Chow, K C

    1. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
      K C Chow, T L Macdonald and W E Ross
      Molecular Pharmacology October 1988, 34 (4) 467-473;

  8. Ciaranello, R D

    1. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
      C A Stratford, G L Tan, M W Hamblin and R D Ciaranello
      Molecular Pharmacology October 1988, 34 (4) 527-536;

  9. Collins, R M

    1. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses.
      S V Jones, J L Barker, N J Buckley, T I Bonner, R M Collins and M R Brann
      Molecular Pharmacology October 1988, 34 (4) 421-426;

  10. Cooney, D A

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  11. Corbin, J D

    1. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase.
      S H Francis, B D Noblett, B W Todd, J N Wells and J D Corbin
      Molecular Pharmacology October 1988, 34 (4) 506-517;

  12. Cotgreave, I A

    1. Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      M Rundgren, D J Porubek, P J Harvison, I A Cotgreave, P Moldéus and S D Nelson
      Molecular Pharmacology October 1988, 34 (4) 566-572;

  13. Crankshaw, D

    1. Two sites of azo reduction in the monooxygenase system.
      F J Peterson, J L Holtzman, D Crankshaw and R P Mason
      Molecular Pharmacology October 1988, 34 (4) 597-603;

  14. Crooke, S T

    1. Subcellular localization of leukotriene D4 receptors in sheep tracheal smooth muscle.
      S Mong, G Chi-Rosso, D W Hay and S T Crooke
      Molecular Pharmacology October 1988, 34 (4) 590-596;

D

  1. DeVico, A L

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

F

  1. Falvey, D

    1. Evidence for the involvement of sulfhydryl compounds in the inhibition of cellular DNA synthesis by selenite.
      G D Frenkel and D Falvey
      Molecular Pharmacology October 1988, 34 (4) 573-577;

  2. Farach, M C

    1. A monoclonal antibody specifically modulates dihydropyridine-sensitive calcium current in BC3H1 myocytes.
      J M Caffrey and M C Farach
      Molecular Pharmacology October 1988, 34 (4) 518-526;

  3. Farber, J L

    1. 1,3-(2-Chloroethyl)-1-nitrosourea potentiates the toxicity of acetaminophen both in the phenobarbital-induced rat and in hepatocytes cultured from such animals.
      M E Kyle, D Nakae, A Serroni and J L Farber
      Molecular Pharmacology October 1988, 34 (4) 584-589;

  4. Fox, I H

    1. Regulation of adenosine kinase by adenosine analogs.
      B B Lin, M C Hurley and I H Fox
      Molecular Pharmacology October 1988, 34 (4) 501-505;

  5. Francis, S H

    1. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase.
      S H Francis, B D Noblett, B W Todd, J N Wells and J D Corbin
      Molecular Pharmacology October 1988, 34 (4) 506-517;

  6. Frenkel, G D

    1. Evidence for the involvement of sulfhydryl compounds in the inhibition of cellular DNA synthesis by selenite.
      G D Frenkel and D Falvey
      Molecular Pharmacology October 1988, 34 (4) 573-577;

  7. Fridland, A

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

G

  1. Garbay-Jaureguiberry, C

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

  2. Geertsen, S

    1. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
      S Geertsen, R Afar, J M Trifaró and M Quik
      Molecular Pharmacology October 1988, 34 (4) 549-556;

  3. Glazer, R I

    1. The epidermal growth factor- and interferon-independent effects of double-stranded RNA in A431 cells.
      M S Chapekar, M C Knode and R I Glazer
      Molecular Pharmacology October 1988, 34 (4) 461-466;

  4. Graham, R M

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;

H

  1. Hamblin, M W

    1. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
      C A Stratford, G L Tan, M W Hamblin and R D Ciaranello
      Molecular Pharmacology October 1988, 34 (4) 527-536;

  2. Hamik, A

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  3. Hao, Z

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  4. Harrington, M A

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  5. Hartman, N R

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  6. Harvison, P J

    1. Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      M Rundgren, D J Porubek, P J Harvison, I A Cotgreave, P Moldéus and S D Nelson
      Molecular Pharmacology October 1988, 34 (4) 566-572;

  7. Hay, D W

    1. Subcellular localization of leukotriene D4 receptors in sheep tracheal smooth muscle.
      S Mong, G Chi-Rosso, D W Hay and S T Crooke
      Molecular Pharmacology October 1988, 34 (4) 590-596;

  8. Highet, R J

    1. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.
      T J Monks, R J Highet and S S Lau
      Molecular Pharmacology October 1988, 34 (4) 492-500;

  9. Hoffman, A J

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  10. Holtzman, J L

    1. Two sites of azo reduction in the monooxygenase system.
      F J Peterson, J L Holtzman, D Crankshaw and R P Mason
      Molecular Pharmacology October 1988, 34 (4) 597-603;

  11. Homcy, C J

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;

  12. Hurley, M C

    1. Regulation of adenosine kinase by adenosine analogs.
      B B Lin, M C Hurley and I H Fox
      Molecular Pharmacology October 1988, 34 (4) 501-505;

I

  1. Icard-Liepkalns, C

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

J

  1. Johns, D G

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  2. Johnson, G L

    1. Transducin inhibition of light-dependent rhodopsin phosphorylation: evidence for beta gamma subunit interaction with rhodopsin.
      D J Kelleher and G L Johnson
      Molecular Pharmacology October 1988, 34 (4) 452-460;

  3. Jones, S V

    1. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses.
      S V Jones, J L Barker, N J Buckley, T I Bonner, R M Collins and M R Brann
      Molecular Pharmacology October 1988, 34 (4) 421-426;

K

  1. Kappus, H

    1. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
      I Mahmutoglu and H Kappus
      Molecular Pharmacology October 1988, 34 (4) 578-583;

  2. Kelleher, D J

    1. Transducin inhibition of light-dependent rhodopsin phosphorylation: evidence for beta gamma subunit interaction with rhodopsin.
      D J Kelleher and G L Johnson
      Molecular Pharmacology October 1988, 34 (4) 452-460;

  3. Knode, M C

    1. The epidermal growth factor- and interferon-independent effects of double-stranded RNA in A431 cells.
      M S Chapekar, M C Knode and R I Glazer
      Molecular Pharmacology October 1988, 34 (4) 461-466;

  4. Kyle, M E

    1. 1,3-(2-Chloroethyl)-1-nitrosourea potentiates the toxicity of acetaminophen both in the phenobarbital-induced rat and in hepatocytes cultured from such animals.
      M E Kyle, D Nakae, A Serroni and J L Farber
      Molecular Pharmacology October 1988, 34 (4) 584-589;

L

  1. Lau, S S

    1. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.
      T J Monks, R J Highet and S S Lau
      Molecular Pharmacology October 1988, 34 (4) 492-500;

  2. Laychock, S G

    1. Relationship between delta-9-tetrahydrocannabinol-induced arachidonic acid release and secretagogue-evoked phosphoinositide breakdown and Ca2+ mobilization of exocrine pancreas.
      A Chaudhry, R H Thompson, R P Rubin and S G Laychock
      Molecular Pharmacology October 1988, 34 (4) 543-548;

  3. Lin, B B

    1. Regulation of adenosine kinase by adenosine analogs.
      B B Lin, M C Hurley and I H Fox
      Molecular Pharmacology October 1988, 34 (4) 501-505;

M

  1. Macdonald, T L

    1. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
      K C Chow, T L Macdonald and W E Ross
      Molecular Pharmacology October 1988, 34 (4) 467-473;

  2. Mahmutoglu, I

    1. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
      I Mahmutoglu and H Kappus
      Molecular Pharmacology October 1988, 34 (4) 578-583;

  3. Mason, R P

    1. Two sites of azo reduction in the monooxygenase system.
      F J Peterson, J L Holtzman, D Crankshaw and R P Mason
      Molecular Pharmacology October 1988, 34 (4) 597-603;

  4. Mathis, C A

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  5. Moldéus, P

    1. Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      M Rundgren, D J Porubek, P J Harvison, I A Cotgreave, P Moldéus and S D Nelson
      Molecular Pharmacology October 1988, 34 (4) 566-572;

  6. Mong, S

    1. Subcellular localization of leukotriene D4 receptors in sheep tracheal smooth muscle.
      S Mong, G Chi-Rosso, D W Hay and S T Crooke
      Molecular Pharmacology October 1988, 34 (4) 590-596;

  7. Monks, T J

    1. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.
      T J Monks, R J Highet and S S Lau
      Molecular Pharmacology October 1988, 34 (4) 492-500;

  8. Muntz, K H

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;

N

  1. Nakae, D

    1. 1,3-(2-Chloroethyl)-1-nitrosourea potentiates the toxicity of acetaminophen both in the phenobarbital-induced rat and in hepatocytes cultured from such animals.
      M E Kyle, D Nakae, A Serroni and J L Farber
      Molecular Pharmacology October 1988, 34 (4) 584-589;

  2. Nelson, S D

    1. Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      M Rundgren, D J Porubek, P J Harvison, I A Cotgreave, P Moldéus and S D Nelson
      Molecular Pharmacology October 1988, 34 (4) 566-572;

  3. Noblett, B D

    1. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase.
      S H Francis, B D Noblett, B W Todd, J N Wells and J D Corbin
      Molecular Pharmacology October 1988, 34 (4) 506-517;

P

  1. Parker, W B

    1. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
      W B Parker, A R Bapat, J X Shen, A J Townsend and Y C Cheng
      Molecular Pharmacology October 1988, 34 (4) 485-491;

  2. Pasquini, F

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

  3. Perno, C F

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  4. Peroutka, S J

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  5. Peterson, F J

    1. Two sites of azo reduction in the monooxygenase system.
      F J Peterson, J L Holtzman, D Crankshaw and R P Mason
      Molecular Pharmacology October 1988, 34 (4) 597-603;

  6. Pierce, P A

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  7. Porubek, D J

    1. Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      M Rundgren, D J Porubek, P J Harvison, I A Cotgreave, P Moldéus and S D Nelson
      Molecular Pharmacology October 1988, 34 (4) 566-572;

Q

  1. Quandt, F N

    1. Modification of slow inactivation of single sodium channels by phenytoin in neuroblastoma cells.
      F N Quandt
      Molecular Pharmacology October 1988, 34 (4) 557-565;

  2. Quik, M

    1. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
      S Geertsen, R Afar, J M Trifaró and M Quik
      Molecular Pharmacology October 1988, 34 (4) 549-556;

R

  1. Roques, B

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

  2. Ross, W E

    1. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
      K C Chow, T L Macdonald and W E Ross
      Molecular Pharmacology October 1988, 34 (4) 467-473;

  3. Rossier, J

    1. Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6.
      P Bochet, C Icard-Liepkalns, F Pasquini, C Garbay-Jaureguiberry, A Beaudet, B Roques and J Rossier
      Molecular Pharmacology October 1988, 34 (4) 436-443;

  4. Rubin, R P

    1. Relationship between delta-9-tetrahydrocannabinol-induced arachidonic acid release and secretagogue-evoked phosphoinositide breakdown and Ca2+ mobilization of exocrine pancreas.
      A Chaudhry, R H Thompson, R P Rubin and S G Laychock
      Molecular Pharmacology October 1988, 34 (4) 543-548;

  5. Rundgren, M

    1. Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      M Rundgren, D J Porubek, P J Harvison, I A Cotgreave, P Moldéus and S D Nelson
      Molecular Pharmacology October 1988, 34 (4) 566-572;

S

  1. Sarngadharan, M G

    1. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
      Z Hao, D A Cooney, N R Hartman, C F Perno, A Fridland, A L DeVico, M G Sarngadharan, S Broder and D G Johns
      Molecular Pharmacology October 1988, 34 (4) 431-435;

  2. Serroni, A

    1. 1,3-(2-Chloroethyl)-1-nitrosourea potentiates the toxicity of acetaminophen both in the phenobarbital-induced rat and in hepatocytes cultured from such animals.
      M E Kyle, D Nakae, A Serroni and J L Farber
      Molecular Pharmacology October 1988, 34 (4) 584-589;

  3. Shen, J X

    1. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
      W B Parker, A R Bapat, J X Shen, A J Townsend and Y C Cheng
      Molecular Pharmacology October 1988, 34 (4) 485-491;

  4. Stratford, C A

    1. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
      C A Stratford, G L Tan, M W Hamblin and R D Ciaranello
      Molecular Pharmacology October 1988, 34 (4) 527-536;

T

  1. Tan, G L

    1. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
      C A Stratford, G L Tan, M W Hamblin and R D Ciaranello
      Molecular Pharmacology October 1988, 34 (4) 527-536;

  2. Thompson, R H

    1. Relationship between delta-9-tetrahydrocannabinol-induced arachidonic acid release and secretagogue-evoked phosphoinositide breakdown and Ca2+ mobilization of exocrine pancreas.
      A Chaudhry, R H Thompson, R P Rubin and S G Laychock
      Molecular Pharmacology October 1988, 34 (4) 543-548;

  3. Todd, B W

    1. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase.
      S H Francis, B D Noblett, B W Todd, J N Wells and J D Corbin
      Molecular Pharmacology October 1988, 34 (4) 506-517;

  4. Townsend, A J

    1. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
      W B Parker, A R Bapat, J X Shen, A J Townsend and Y C Cheng
      Molecular Pharmacology October 1988, 34 (4) 485-491;

  5. Trifaró, J M

    1. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
      S Geertsen, R Afar, J M Trifaró and M Quik
      Molecular Pharmacology October 1988, 34 (4) 549-556;

W

  1. Wang, S S

    1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
      S J Peroutka, A Hamik, M A Harrington, A J Hoffman, C A Mathis, P A Pierce and S S Wang
      Molecular Pharmacology October 1988, 34 (4) 537-542;

  2. Wells, J N

    1. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase.
      S H Francis, B D Noblett, B W Todd, J N Wells and J D Corbin
      Molecular Pharmacology October 1988, 34 (4) 506-517;

  3. White, M M

    1. Forskolin alters acetylcholine receptor gating by a mechanism independent of adenylate cyclase activation.
      M M White
      Molecular Pharmacology October 1988, 34 (4) 427-430;

  4. Willerson, J T

    1. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
      K H Muntz, T A Calianos, L M Buja, J T Willerson, M Bernatowicz, C J Homcy and R M Graham
      Molecular Pharmacology October 1988, 34 (4) 444-451;
Back to top

In this issue

Advertisement